CTC presence analyzed with Adna Breast Test (detection of EpCAM-, MUC-1-, and HER-2-transcripts) together with CA 125 assessment were shown to be of prognostic significance in gynecological cancers [43]. This evidence concerns the gene MUC1 and female reproductive organ cancer.